Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Symptom improvement | |||||
Systematic review |
47 people with plaque, pustular, or erythrodermic psoriasis affecting more than 20% of body surface; proportion of people with chronic plaque psoriasis not reported Data from 1 RCT |
Proportion of people with marked improvement or clearance
time of assessment not reported
20/25 (80%) with liquid oral 8-methoxsalen in PUVA 12/22 (55%) with crystalline oral 8-methoxsalen in PUVA |
ARI +25% 95% CI –1% to +51% |
Not significant |